[ad_1]
On the 18th (local time), a woman with a child in her arms at Litchfield Cathedral in Litchfield, central England, will receive the AstraZeneca vaccine. The European Medicines Agency (EMA) today held an extraordinary meeting of the Safety Committee and concluded that the AstraZeneca vaccine “was not associated with an overall increased risk of blood clots.” Following the EMA announcement, Germany and France decided to resume vaccination against AstraZeneca, which had been discontinued. [AFP=연합뉴스]
The European Medicines Agency (EMA) has concluded that the new vaccine against coronavirus infection (Corona 19) from AstraZeneca (AZ) is “safe and effective”.
Resumption of vaccinations in Germany, France, Spain, etc.
Sye-gyun Jeong “Organize your position clearly”
The Korea Disease Services Agency will release the results of the review on the 22nd
On the 18th (local time), the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) announced that “AZ vaccine is not considered to be associated with an increased risk of blood clot formation (blood clots)” . EMA Commissioner Emma Cook said: “The benefits of the vaccine outweigh the risk of side effects,” she said. “I would get the vaccine tomorrow.” The EMA added that it is difficult to clearly rule out the association between certain types of rare thrombotic symptoms and the AZ vaccine. Recently, the World Health Organization (WHO) also issued an official statement recommending vaccination, saying: “Thrombosis is a common disease regardless of vaccination.” According to the EMA, of the 20 million people who received the AZ vaccine in the UK and the European Economic Area (EEA), seven had disseminated intravascular coagulation and 18 had cerebral sinus thrombosis, of which nine died. Most were under 55 years old. According to the EMA’s decision, Germany, France, Italy and Spain will resume AZ vaccination. French Prime Minister Jean Castex will administer the vaccine first on the 19th to ease public anxiety.
Korean quarantine authorities also decided to continue vaccination scheduled for after this month, including 377,000 people aged 65 and over in hospitals and nursing facilities. According to the Central Defense Countermeasures Headquarters, of the 7.75,000 vaccines to be introduced in April-June, the AZ vaccine represents 4.25,000 or 54.6%. Prime Minister Jeong Sye-gyun gave an urgent order to the Korean Centers for Disease Control and Prevention on this day, saying: “Quickly convene the Specialized Committee on Vaccination to thoroughly review the evaluation data of the World Organization. of Health (WHO) and EMA and cases of adverse reactions in Korea, and clearly order your position. ” This is because two cases of suspected blood clot formation have been reported in Korea after vaccination. The Corona 19 Vaccination Response Advocacy Team is scheduled to announce the results on the 22nd. Jeong Ki-seok, professor of respiratory medicine at Hallym University Sacred Heart Hospital, said: “They should get vaccinated, but thoroughly investigate cases of blood clots. ” Said.
Reporters Minwook Kim, Minjung Lee, Woorim Lee [email protected]
[ad_2]
